These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1117 related items for PubMed ID: 9066703

  • 21. The role of nm23-H1 in the progression of transitional cell bladder cancer.
    Chow NH, Liu HS, Chan SH.
    Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
    [Abstract] [Full Text] [Related]

  • 22. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin.
    Reichrath J, Seyfried P, Braun R, Müller SM, Baum HP, Bahmer FA.
    Dermatology; 1997 Sep; 194(2):136-9. PubMed ID: 9094461
    [Abstract] [Full Text] [Related]

  • 23. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
    Oda Y, Naka T, Takeshita M, Iwamoto Y, Tsuneyoshi M.
    Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
    [Abstract] [Full Text] [Related]

  • 24. Tumor metastasis and nm23: current concepts.
    Steeg PS, Cohn KH, Leone A.
    Cancer Cells; 1991 Jul; 3(7):257-62. PubMed ID: 1911039
    [Abstract] [Full Text] [Related]

  • 25. Nm23 expression in breast ductal carcinomas: a ten year follow-up study in a uniform group of node-negative breast cancer patients.
    Kapranos N, Karaiossifidi H, Kouri E, Vasilaros S.
    Anticancer Res; 1996 Jul; 16(6C):3987-90. PubMed ID: 9042324
    [Abstract] [Full Text] [Related]

  • 26. Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study.
    van den Oord JJ, Maes A, Stas M, Nuyts J, De Wever I, De Wolf-Peeters C.
    Melanoma Res; 1997 Apr; 7(2):121-8. PubMed ID: 9167178
    [Abstract] [Full Text] [Related]

  • 27. NM23 protein in neoplastic and nonneoplastic thyroid tissues.
    Bertheau P, De La Rosa A, Steeg PS, Merino MJ.
    Am J Pathol; 1994 Jul; 145(1):26-32. PubMed ID: 8030752
    [Abstract] [Full Text] [Related]

  • 28. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
    Sarris M, Lee CS.
    Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
    [Abstract] [Full Text] [Related]

  • 29. Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma.
    Ferrari D, Lombardi M, Ricci R, Michiara M, Santini M, De Panfilis G.
    J Cutan Pathol; 2007 Sep; 34(9):705-12. PubMed ID: 17696918
    [Abstract] [Full Text] [Related]

  • 30. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
    Al-Maghrabi JA, Asa SL.
    Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Immunocytochemical detection of prostate specific antigen expression in human primary and metastatic melanomas.
    Bodey B, Bodey B, Kaiser HE.
    Anticancer Res; 1997 May; 17(3C):2343-6. PubMed ID: 9216712
    [Abstract] [Full Text] [Related]

  • 33. Identification of the tumor metastasis suppressor Nm23-H1/Nm23-R1 as a constituent of the centrosome.
    Roymans D, Vissenberg K, De Jonghe C, Willems R, Engler G, Kimura N, Grobben B, Claes P, Verbelen JP, Van Broeckhoven C, Slegers H.
    Exp Cell Res; 2001 Jan 15; 262(2):145-53. PubMed ID: 11139339
    [Abstract] [Full Text] [Related]

  • 34. Nm23 'anti-metastatic' gene product expression in colorectal carcinoma.
    Royds JA, Cross SS, Silcocks PB, Scholefield JH, Rees RC, Stephenson TJ.
    J Pathol; 1994 Mar 15; 172(3):261-6. PubMed ID: 8195929
    [Abstract] [Full Text] [Related]

  • 35. Nm23 and cathepsin D expression in laryngeal carcinomas.
    Hadice Elif Pestereli, Gulay Ozbilim, Ozlem Elpek, Firat Fisenk, Esor Balkan.
    Adv Clin Path; 2000 Jul 15; 4(3):121-5. PubMed ID: 11080791
    [Abstract] [Full Text] [Related]

  • 36. [Nucleoside diphosphate kinase/Nm23 and metastatic potency].
    Lacombe ML.
    Bull Cancer; 1993 Aug 15; 80(8):717-22. PubMed ID: 8204954
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis.
    Luo W, Matsuo K, Nagayama Y, Urano T, Furukawa K, Takeshita A, Nakayama T, Yokoyama N, Yamashita S, Izumi M.
    Thyroid; 1993 Aug 15; 3(2):105-9. PubMed ID: 8396479
    [Abstract] [Full Text] [Related]

  • 39. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.
    Sauer T, Furu I, Beraki K, Jebsen PW, Ormerod E, Naess O.
    Cancer; 1998 Apr 25; 84(2):109-14. PubMed ID: 9570214
    [Abstract] [Full Text] [Related]

  • 40. The association of the Nm23-M1 protein and beta-tubulin correlates with cell differentiation.
    Lombardi D, Sacchi A, D'Agostino G, Tibursi G.
    Exp Cell Res; 1995 Apr 25; 217(2):267-71. PubMed ID: 7698225
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.